Hoffman Reid's Form 4 filing
Vor Biopharma Inc. (VOR) · filed Aug 27, 2025
- Accession no.
- 0001415889-25-023165
- Filed
- Aug 27, 2025, 5:25 PM ET
- Trade date
- Aug 25-26, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.41M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman ReidCIK 0001519339 | 10% Owner |
| Reprogrammed Interchange LLCCIK 0002050755 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2025 | Common Stock | SSaleDisposed | −387,346 | $2.12 | −$819,740.34 | 38,586,755 | Direct | |
| Aug 26, 2025 | Common Stock | SSaleDisposed | −284,190 | $2.08 | −$591,342.55 | 38,302,565 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.